Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dear Doc Singapore
AddedFeb 18, 2024
UpdatedJun 18, 2026
Dear Doc Singapore

Dear Doc Singapore

Dear Doc: Simplifying and personalizing women's healthcare solutions in Asia.

HQ
Singapore, Singapore, SG
Founded
2020
Accelerator
Techstars logoTechstars: Tel Aviv2023
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to simplify and personalize healthcare for women in Asia, Dear Doc Singapore focuses on providing accessible, discreet, and affordable medical care specifically for birth control. Their core product, the Dear Doc App, offers a one-stop solution for women to access sensitive medical care from the comfort of their homes. The app connects users with non-judgmental female doctors who review health profiles and discuss suitable birth control options, ensuring a personalized healthcare experience.

Notable affiliated individuals include a team of experienced female doctors dedicated to providing judgment-free consultations. Key achievements for Dear Doc include the successful launch and adoption of their app, which has significantly improved access to birth control solutions for women across Asia. The overall impact of Dear Doc has been profound, as it has empowered women to take control of their reproductive health in a private and supportive environment.

Dear Doc Singapore - Quick Facts

When was Dear Doc Singapore founded?

Dear Doc Singapore was founded in 2020.

Where is Dear Doc Singapore's headquarters located?

Dear Doc Singapore's headquarters is located in Singapore, Singapore, SG.

When was Dear Doc Singapore's last funding round?

Dear Doc Singapore's most recent funding round was for $20k (USD) in October 2023.

How much has Dear Doc Singapore raised to-date?

As of Oct 18, 2023, Dear Doc Singapore has raised a total of $20k (USD).

How many employees does Dear Doc Singapore have?

Dear Doc Singapore has 1 employee as of Feb 4, 2024.

Dear Doc Singapore - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Asia
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Birth Control
Tags
  • Healthtech